📖 Approx. 4 min ／ Updated 2026.06.16
In this article, an M&A advisor specializing in the healthcare industry explains from a practical perspective how share transfers become a key issue in due diligence for business succession and medical M&As. We will share specific measures based on investigations into financial, legal, labor, and clinical practices, as well as the transfer of equity interests in medical corporations.
1. Industry Background of Share Transfer Due Diligence
According to the Dynamic Survey of Medical Institutions by the Ministry of Health, Labour and Welfare, the business environment for medical institutions, including due diligence, has become increasingly challenging in recent years due to a combination of factors such as medical fee revisions, rising labor costs, and the burden of capital investment. In particular, interest in third-party succession M&A is growing from the perspective of financial, legal, labor, and clinical practice investigations.
At the same time, share transfers are a crucial point of discussion in medical M&A practice. By appropriately structuring the transfer of equity interests in a medical corporation, a succession that benefits both the transferor and the transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the workflow, patient base, and equipment status unique to due diligence, and clarify the transfer terms.
- Valuation: Calculate an appropriate transfer price range based on the characteristics of the clinical department. In due diligence, investigations into financial, legal, labor, and clinical practices are key to the valuation.
- Structuring Share Transfers: Selecting the optimal scheme based on the transfer of equity interests in the medical corporation. Verification from tax, legal, and labor perspectives is also required.
- Sourcing & Matching: Select buyer candidates that match the characteristics of the clinical department from a nationwide network. Carefully align the desired conditions of both parties.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and clinical practice perspectives. Also verify permits, licenses, and facility standards unique to due diligence.
- Final Agreement & Closing: Execute the final agreement, including representations and warranties and indemnification clauses. Proceed with the transfer of permits and licenses and staff announcements in parallel.
3. Specific Considerations in Due Diligence
In medical institution M&A due diligence, investigations into financial, legal, labor, and clinical practices hold the key to a successful succession. There are numerous individual issues depending on the characteristics of the clinical department, such as the continuity of the patient base, retention of staff (physicians, nurses, and allied health professionals), the condition and replacement plans of equipment, and the maintenance or acquisition of facility standards.
In addition, strategic design based on market characteristics unique to due diligence is crucial, such as the mix of insurance-covered and self-pay services, the status of regional medical cooperation, and relationships with neighboring competing medical institutions. Leveraging our track record in supporting successions through due diligence, we support practical operations from an industry-specialized perspective.
4. Practical Details of Share Transfers
Share transfers are an area that requires specialized consideration in medical M&A. Structuring the transaction with the transfer of equity interests in the medical corporation in mind is the key to success.
- Review of Relevant Laws and Practical Standards: Preparation in compliance with the Medical Care Act, tax laws, and labor regulations
- Collaboration with Experts: Working with certified public accountants, tax accountants, attorneys, and labor attorneys
- Risk Assessment: Identifying potential risks and formulating mitigation policies
- Consensus Building Between Parties: Designing mutually satisfactory terms for both the transferor and the transferee
- Proper Documentation: Clearly specifying terms in the letter of intent (LOI) and the final agreement
Frequently Asked Questions
Q. What documents are required for the initial consultation?
A. It will facilitate a smooth process if you can prepare financial statements for the last three fiscal years, patient volume trends, staff composition, an equipment list, and lease agreements (if applicable) in advance. We will collect these after executing a non-disclosure agreement (NDA).
Q. What is the typical valuation range for a transfer?
A. Valuation is based on investigations into financial, legal, labor, and clinical practices. As a guideline, clinics without beds are valued at 0.5 to 1.5 times annual revenue, while clinics with beds or hospitals are valued at 3 to 7 times EBITDA. We can provide details through our free simplified valuation.
Q. What should I keep in mind when proceeding with a share transfer?
A. Prior structuring that takes into account the transfer of equity interests in the medical corporation is essential. Flawless execution through collaboration with experts is the key to success.
Q. Will my staff or patients find out about the consultation?
A. Information is disclosed on a limited basis only after an NDA is signed, and no disclosure to stakeholders is made before the final agreement. We strictly maintain confidentiality.
Related Articles
- Complete Guide to Business Succession for Hospitals and Medical Corporations | Medical M&A Practice from Successor Shortages to Success Stories
- Complete Guide to Clinic Sales and Transfers | Price Range, Process, and Key Points Explained by Medical M&A Experts
- How to Proceed with Medical M&A and Hospital Succession | 6 Steps from Consultation to Closing Explained with Real Examples
- Complete Guide to Tax Schemes for Medical Corporation M&A | Key Points for Tax Accountants and CPAs
Contact M&A Medical for Consultations on Share Transfer Due Diligence
Strict Confidentiality • Free Initial Consultation • Success Fee Basis